Your browser doesn't support javascript.
loading
Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease.
Theberge, I; Bowdridge, J; Forgie, M A; Carrier, M; Louzada, M; Siquiera, L; Rhodes, M; Wells, P S.
Afiliação
  • Theberge I; Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada. Electronic address: itheb007@uottawa.ca.
  • Bowdridge J; Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
  • Forgie MA; Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
  • Carrier M; Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
  • Louzada M; Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
  • Siquiera L; Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
  • Rhodes M; Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
  • Wells PS; Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada. Electronic address: pwells@toh.ca.
Thromb Res ; 152: 4-6, 2017 04.
Article em En | MEDLINE | ID: mdl-28192715
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Tromboembolia Venosa / Inibidores do Fator Xa / Rivaroxabana / Neoplasias Idioma: En Revista: Thromb Res Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Tromboembolia Venosa / Inibidores do Fator Xa / Rivaroxabana / Neoplasias Idioma: En Revista: Thromb Res Ano de publicação: 2017 Tipo de documento: Article